PGAM5 and hepatocellular carcinoma: Consistent with the report by Chan et al., we found no evidence to suggest that PGAM5 knockdown significantly affected the necroptosis biomarkers MLKL in HCC cell lines after 5-Fu treatment (Supplementary Fig. S7).